Almirall, S.A. Almirall, S.A.

Almirall, S.A.

ALM

Rank in Stocks #5085
Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery,... Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the United States, its product line targets various dermatological ailments such as actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, and acne, alongside rare skin conditions. Beyond its core dermatology focus, the company also offers solutions for cardiovascular, musculoskeletal, respiratory, and nervous system disorders, as well as products for digestive health, anti-infectives for systemic use, genitourinary conditions and sex hormones, immunostimulants, and systemic hormonal preparations. Its extensive portfolio includes a range of well-known medications, such as Ilumetri, Solaraze, Skilarence, and Klisyri, among others. Almirall fosters strategic partnerships with numerous entities to advance its pipeline, including research institutions like the University of Dundee and commercial partners such as Eli Lilly and Company. Founded in Barcelona, Spain, in 1943, the company adopted its current name, Almirall, S.A., in May 2009, having previously been known as Laboratorios Almirall, S.A.
Share Price
$11.55
Last synced: 2026-11-17
Market Cap
$2.52B
Change (1 day)
-1.54%
Change (1 year)
-19.98%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Almirall, S.A. (ALM)
EPS as of September 2026 TTM: $0.37
According to Almirall, S.A.'s latest financial reports, its current EPS (TTM) is $0.37. At the end of 2025 the company had an EPS of $0.26, an increase over its 2024 EPS of $0.05.
EPS history for Almirall, S.A. from 2004 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.37 44.15%
2025 $0.26 417.23%
2024 $0.05 -122.57%
2023 $-0.22 -970.47%
2022 $0.03 -109.71%
2021 $-0.26 -151.12%
2020 $0.51 -25.26%
2019 $0.68 45.25%
2018 $0.47 -122.31%
2017 $-2.11 -556.11%
2016 $0.46 -43.89%
2015 $0.83 -73.67%
2014 $3.13 -1,299.31%
2013 $-0.26 -145.02%
2012 $0.58 -12.09%
2011 $0.66 -30.45%
2010 $0.95 -27.25%
2009 $1.30 14.18%
2008 $1.14 -1.04%
2007 $1.15 -1.39%
2006 $1.17 39.60%
2005 $0.84 10.48%
2004 $0.76 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 1,508.83%
DE
$6.01 1,502.93%
DE
$1.53 308.99%
JP
$3.66 876.52%
CH
$0.45 20.06%
IL

Questions about Almirall, S.A.'s earnings per share (EPS)

What is Almirall, S.A.'s earnings per share (EPS)?

Almirall, S.A.'s earnings per share (EPS) over the last twelve months is $0.37, as of Sep 2026.

What was Almirall, S.A.'s earnings per share (EPS) in 2025?

In 2025, Almirall, S.A.'s earnings per share (EPS) was $0.26, 420.00% more than in 2024 ($0.05).

How has Almirall, S.A.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Almirall, S.A.'s earnings per share (EPS) went from $0.51 to $0.26, an average decline of 12.61% a year.

How does Almirall, S.A.'s earnings per share (EPS) compare with similar companies?

Almirall, S.A.'s earnings per share (EPS) ($0.37) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.